POPA ReconResearchers found that continuous glucose monitors significantly improved blood sugar control in adults with type 2 diabetes who do not use…
Researchers found that continuous glucose monitors significantly improved blood sugar control in adults with type 2 diabetes who do not use insulin. In a 26-week trial, CGM users spent about five more hours per day in the target glucose range and achieved a 0.9-point greater reduction in A1c than patients receiving routine care. https://www.nejm.org/doi/10.1056/NEJMoa2608571
The excerpt is quoted from a public Telegram channel, which owns its text.